Buy Artrocal Hampton Injection Online
Advanced Joint & Cartilage Support for Horses
Artrocal Hampton Injection is a veterinary injectable chondroprotective product formulated with chondroitin sulfate and glucosamine sulfate. Product information describes it for horses, dogs, and cats as supportive therapy for osteoarticular conditions and musculoskeletal problems involving joints, cartilage, tendons, and related structures.
The formulation combines 12% chondroitin sulfate with 20% glucosamine sulfate, providing two compounds associated with the structural components of articular cartilage and connective tissues. The product is supplied in a package of 5 × 5 mL vials.
For equine use, Artrocal Hampton is particularly positioned as a veterinary joint-support option for horses experiencing musculoskeletal demands associated with training, athletic activity, age-related changes, or diagnosed osteoarticular conditions. Its use should be determined by a veterinarian according to the individual horse’s condition and applicable product regulations.
What Is Artrocal Hampton Injection?
Artrocal Hampton is an injectable veterinary chondroprotective formulation containing chondroitin sulfate and glucosamine sulfate. Available product information identifies it for use in horses, dogs, and cats and describes its role in the management and prevention of various osteoarticular conditions.
The product is associated with Laboratorio Calastremé in available product listings. It is presented as a sterile injectable preparation in 5 mL vials, with five vials per package.
Rather than being an analgesic or corticosteroid, Artrocal Hampton belongs to the chondroprotective/joint-support category. Product information focuses on supporting cartilage and musculoskeletal structures through its combination of glucosamine and chondroitin.
This distinction is important when evaluating a joint-care product. A chondroprotective formulation should not automatically be considered interchangeable with an NSAID, corticosteroid, intra-articular hyaluronic acid product, or other veterinary treatment. The appropriate choice depends on the diagnosis, severity, location of the problem, and veterinary treatment plan.
Artrocal Hampton Product Overview
| Product detail | Information |
|---|---|
| Product | Artrocal Hampton |
| Product type | Veterinary injectable chondroprotective product |
| Primary species | Horses, dogs and cats |
| Chondroitin sulfate | 12% solution |
| Glucosamine sulfate | 20% solution |
| Amount per 1 mL | 120 mg chondroitin sulfate + 200 mg glucosamine sulfate |
| Presentation | 5 × 5 mL vials |
| Primary area of use | Osteoarticular and musculoskeletal support |
| Manufacturer/laboratory identified in product information | Calastremé |
| Equine administration | Product information specifies intramuscular administration; veterinary supervision is appropriate |
The composition of 120 mg chondroitin sulfate and 200 mg glucosamine sulfate per mL is stated in the available product information.
Because veterinary products can have different registrations, labels, and permitted uses between countries, the packaging and locally applicable label should always be checked before use.
Active Ingredients
Chondroitin Sulfate
Chondroitin sulfate is a glycosaminoglycan associated with the extracellular matrix of cartilage and other connective tissues. In veterinary joint-support products, it is commonly included because of its relationship to cartilage structure and joint tissues.
Artrocal Hampton is described as containing a 12% chondroitin sulfate solution, corresponding to 120 mg per mL according to the available product information.
Glucosamine Sulfate
Glucosamine is another compound associated with the synthesis of structural components found in cartilage and connective tissue.
Artrocal Hampton contains a 20% glucosamine sulfate solution, corresponding to 200 mg per mL.
Combined Formulation
The combination of these two ingredients is a central feature of Artrocal Hampton. Product information describes the formulation as intended to support cartilage and the musculoskeletal system, rather than functioning primarily as a conventional painkiller.
This makes the product relevant to veterinary protocols where joint and cartilage support is part of a broader management strategy.
Key Features
Artrocal Hampton Injection offers several identifiable product characteristics:
- Injectable veterinary formulation.
- Contains chondroitin sulfate and glucosamine sulfate.
- Designed for osteoarticular and musculoskeletal support.
- Available for horses, dogs, and cats according to product information.
- Contains 120 mg of chondroitin sulfate per mL.
- Contains 200 mg of glucosamine sulfate per mL.
- Supplied as five 5 mL vials.
- Intended for professional veterinary use.
- Product information identifies intramuscular administration for horses.
Equine Joint and Musculoskeletal Support
Healthy joints are essential to normal movement in horses. The equine musculoskeletal system experiences substantial mechanical demands during training, competition, work, jumping, racing, and other physical activities.
Joint-related problems can involve cartilage, synovial structures, tendons, ligaments, surrounding tissues, or bone. For this reason, joint support should not be approached as a single-condition treatment.
Veterinarians may consider several factors when assessing an equine musculoskeletal problem, including:
- The horse’s age.
- Previous injuries.
- Training intensity.
- Current workload.
- Lameness history.
- Joint location.
- Radiographic or ultrasound findings where appropriate.
- Presence of inflammation.
- Degenerative changes.
- Tendon or ligament involvement.
- Recovery following surgery or injury.
- The horse’s overall health.
Artrocal Hampton’s formulation is positioned within this broader veterinary context as a source of chondroitin and glucosamine for osteoarticular support.
It should not, however, be represented as a universal treatment for every cause of lameness or joint discomfort.
Veterinary Uses and Clinical Context
Available product information lists Artrocal Hampton in connection with a range of osteoarticular and musculoskeletal conditions. These include non-infectious arthritis, osteoarthritis, periarthritis, spondylarthrosis, osteochondrosis, tendinitis, synovitis, disc-related disorders, chondropathy, traumatic injuries involving ligament and tendon structures, and post-surgical musculoskeletal care.
The product is also described in relation to:
- Osteoarticular pathology.
- Certain fracture-related support protocols.
- Recovery following osteoarticular surgery.
- Age-related musculoskeletal changes.
- Periods of increased physical activity.
- Musculoskeletal support during intensive athletic workloads.
These descriptions represent the product information available from the sources reviewed and should not be interpreted as a diagnosis for a particular horse.
A veterinarian should determine whether the underlying condition is appropriate for this type of therapy.
Chondroitin Sulfate and Glucosamine Sulfate
The rationale behind Artrocal Hampton is its combination of two compounds commonly associated with cartilage and connective-tissue biology.
Chondroitin sulfate is a structural glycosaminoglycan found in cartilage, while glucosamine participates in pathways involved in the production of glycosaminoglycans and other connective-tissue components.
The product’s formulation therefore differs from medications whose principal purpose is to suppress pain or inflammation.
That distinction can be useful when discussing equine joint care. A horse may require diagnostic investigation and a combination of management approaches rather than relying on one injectable product alone.
Depending on the condition, a veterinarian may consider exercise modification, rehabilitation, farriery, imaging, anti-inflammatory medication, intra-articular therapies, physical therapy, or other interventions alongside joint-support products.
Important Safety Considerations
Artrocal Hampton should be treated as a veterinary injectable product rather than an ordinary nutritional supplement.
The product information reviewed states that hypersensitivity to its components is a relevant contraindication and that pregnancy requires particular caution because safety has not been established in pregnant females in the cited product information.
Before administration, the veterinarian should consider:
- The horse’s diagnosis.
- Previous reactions to injectable products.
- Current medications and supplements.
- Pregnancy status where relevant.
- Existing systemic illness.
- The horse’s competition status.
- Applicable veterinary regulations.
- The specific product label available in the country of use.
Any unexpected reaction following administration should receive prompt veterinary attention.
Injectable Products Require Professional Handling
Injection carries risks that are not present with ordinary oral supplements. These can include injection-site reactions, contamination, incorrect administration, tissue injury, and adverse reactions.
The product source specifically advises that injectable interventions should be performed by a veterinarian.
For that reason, World Equine Vet should present Artrocal Hampton as a product requiring appropriate veterinary oversight rather than encouraging unsupervised injection.
Administration and Veterinary Supervision
Available product information specifies intramuscular administration for horses.
Some online listings describe additional routes, but because route information can differ between formulations, markets, or product versions, the current manufacturer’s label and local veterinary requirements should take precedence.
For a regulated injectable product, the appropriate amount, frequency, treatment duration, and repeat-course decisions should be determined by the responsible veterinarian.
This is particularly important because treatment requirements can differ substantially according to the horse’s weight, diagnosis, severity of disease, concurrent therapies, and response to treatment.
Storage and Product Handling
Storage requirements should be taken from the current packaging and manufacturer’s instructions supplied with the specific product.
Keep the product appropriately protected from unsuitable environmental conditions and prevent unauthorized access.
Before use, veterinary personnel should inspect the packaging and solution for any obvious signs of damage, contamination, or deterioration. Do not use a vial if its integrity is questionable.
Because Artrocal Hampton is supplied in multiple small vials, proper handling is also important for maintaining product integrity during a veterinary treatment course.
Sport Horse and Competition Considerations
Artrocal Hampton is marketed in some product information for sport horses and horses subjected to intensive physical activity.
Some product sources state that Artrocal Hampton does not contain substances prohibited under certain Jockey Club and FEI rules.
However, competition regulations can change, and medication-control rules may differ between organizations, jurisdictions, events, and disciplines.
A statement on a commercial product page should therefore not be treated as a guarantee that use is permitted in every competition.
Owners and trainers should check the current rules applicable to their particular governing body and event and discuss treatment timing with the attending veterinarian.
Purchasing Artrocal Hampton
When purchasing Artrocal Hampton, customers should verify the exact product name, formulation, presentation, manufacturer information, and packaging.
The standard presentation identified in the sources reviewed is five 5 mL vials.
Because veterinary medicines can be subject to different registration and supply requirements in different countries, availability should not be assumed to be identical worldwide.
Before ordering, customers should also consider whether the product is legally available and permitted for veterinary use in their destination.
Where To Buy Artrocal Hampton Injection Online
If you are researching where to buy Artrocal Hampton Injection online, World Equine Vet can provide product information and purchasing details for customers looking for equine veterinary products.
Artrocal Hampton is a specialized injectable formulation containing chondroitin sulfate and glucosamine sulfate, so customers should verify the product presentation and applicable purchasing requirements before placing an order.
Availability, prescription requirements, import rules, and veterinary-medicine regulations can vary by destination. Customers are responsible for ensuring that any purchase and importation complies with the laws applicable in their location.
For veterinary use, the product should be administered according to the current product information and under appropriate professional supervision.
Frequently Asked Questions
What is Artrocal Hampton Injection?
Artrocal Hampton is a veterinary injectable chondroprotective product containing chondroitin sulfate and glucosamine sulfate. Available product information identifies it for horses, dogs, and cats and associates it with osteoarticular and musculoskeletal support.
What does Artrocal Hampton contain?
The formulation is described as containing 12% chondroitin sulfate and 20% glucosamine sulfate. Product information gives the corresponding amounts as 120 mg and 200 mg per mL, respectively.
How is Artrocal Hampton supplied?
The product is supplied in a package containing 5 vials of 5 mL each.
Is Artrocal Hampton used in horses?
Yes. Product information specifically identifies horses among the intended animal species and describes use in connection with osteoarticular and musculoskeletal conditions.
What conditions is Artrocal Hampton associated with?
Available product information lists conditions including non-infectious arthritis, osteoarthritis, osteochondrosis, tendinitis, synovitis, chondropathy, certain ligament and tendon injuries, osteoarticular pathology, and post-surgical musculoskeletal care.
Is Artrocal Hampton an anti-inflammatory drug?
The product is primarily described as a chondroprotective/joint-support formulation containing chondroitin sulfate and glucosamine sulfate. It should not automatically be considered equivalent to NSAIDs or corticosteroid anti-inflammatory medicines.
Is Artrocal Hampton suitable for sport horses?
Product information identifies the product for sport horses and horses undergoing intensive physical activity. However, competition regulations should always be checked against the current rules of the applicable organization or event.
How is Artrocal Hampton administered to horses?
The product information reviewed specifies intramuscular administration for horses. Administration of veterinary injectables should be performed under appropriate veterinary supervision.
Can Artrocal Hampton be used in pregnant animals?
The Ekinos product information states that it should not be used in pregnant females because safety has not been established during pregnancy. The current product label and veterinarian’s assessment should be followed.
Can Artrocal Hampton replace veterinary diagnosis?
No. Joint stiffness or lameness can have many causes, including orthopedic injury, tendon or ligament problems, infection, hoof problems, neurological conditions, and degenerative disease. A veterinary examination is important before selecting treatment.
Where can I buy Artrocal Hampton Injection?
Artrocal Hampton may be available through veterinary-product suppliers, depending on the destination and applicable regulations. World Equine Vet can provide product information and purchasing details, subject to local availability and legal requirements.
Summary
Artrocal Hampton Injection is a veterinary chondroprotective formulation combining 12% chondroitin sulfate with 20% glucosamine sulfate. The available product information identifies horses, dogs, and cats as intended species and associates the product with osteoarticular and musculoskeletal support.
The standard presentation identified in the sources reviewed is 5 × 5 mL vials, with each milliliter containing 120 mg of chondroitin sulfate and 200 mg of glucosamine sulfate.
For horses, the product information specifies intramuscular administration and describes use in a range of joint and musculoskeletal contexts. Because regulations, labels, and permitted veterinary uses can vary between countries, the current product information and advice from a qualified veterinarian should guide use.
INDICATIONS:
Osteoarticular regenerator, promoter of chondrogenesis, antiarthrosic, non-infectious arthritis, osteoarthritis, hydrarthrosis and other degenerative astropathies, chondropathies, synovitis, tendinitis. Adjuvant in the treatment and prophylaxis of osteoarticular pathologies, adjuvant in fracture repair and post-osteoraticular surgery.
Osteochondrosis. Joint anti-inflammatory.artrocal hampton
CONTRAINDICATIONS:
The product should not be applied to those animals that show hypersensitivity to any of the components. Do not use in pregnant females because its safety has not been gestated.
DOSAGE AND ROUTES OF ADMINISTRATION:
Sports equines:
In acute cases:
Two attack: 1 ml every 80-100 kilos of weight every 24 hours 3-4 days
Maintenance dose: 1 ml every 80-100 kilos of weight every 7 days.
In chronic cases: 1 ml every 80-100 kilos of weight every 7 days.
The medication does not have a painkiller, analgesic or anti-inflammatory, it is therefore a natural medication and hence its absence of intolerance. Administer exclusively intramuscularly.
PRESENTATION: Container containing 5 x 5 ml ampoule vials.
Chondroitin sulfate 12%
Glucosamine 20%

Reviews
There are no reviews yet.